Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results

Our experience indicates that the use of an LVAD as DT in patients with dystrophinopathies with end-stage DCM is feasible, suggesting that it may be suitable as a palliative therapy for the treatment of these patients with no other therapeutic options.